REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 81 filers reported holding REPARE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,000 | -22.7% | 1,400 | -33.1% | 0.00% | – |
| Q2 2023 | $22,000 | +266.7% | 2,093 | +230.6% | 0.00% | – |
| Q1 2023 | $6,000 | -40.0% | 633 | -7.2% | 0.00% | – |
| Q4 2022 | $10,000 | +25.0% | 682 | +9.1% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 625 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 625 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -55.0% | 625 | -30.8% | 0.00% | – |
| Q4 2021 | $20,000 | -42.9% | 903 | -32.0% | 0.00% | – |
| Q3 2021 | $35,000 | -12.5% | 1,328 | +4.7% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 1,268 | -6.5% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 1,356 | +86.0% | 0.00% | – |
| Q4 2020 | $25,000 | +316.7% | 729 | +264.5% | 0.00% | – |
| Q3 2020 | $6,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |